Millennium Management’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$619K Buy
+83,609
New +$619K ﹤0.01% 3255
2025
Q1
Sell
-31,839
Closed -$1.14M 4248
2024
Q4
$1.14M Buy
31,839
+21,448
+206% +$767K ﹤0.01% 2819
2024
Q3
$491K Sell
10,391
-17,280
-62% -$817K ﹤0.01% 3309
2024
Q2
$1.39M Sell
27,671
-32,632
-54% -$1.64M ﹤0.01% 2691
2024
Q1
$6.75M Sell
60,303
-75,475
-56% -$8.45M ﹤0.01% 1767
2023
Q4
$7.88M Buy
135,778
+48,672
+56% +$2.82M ﹤0.01% 1624
2023
Q3
$2.77M Buy
87,106
+12,229
+16% +$388K ﹤0.01% 2272
2023
Q2
$6.16M Buy
74,877
+24,435
+48% +$2.01M ﹤0.01% 1784
2023
Q1
$5.18M Sell
50,442
-96,099
-66% -$9.87M ﹤0.01% 1906
2022
Q4
$21.5M Sell
146,541
-4,826
-3% -$707K 0.01% 952
2022
Q3
$25.6M Sell
151,367
-23,941
-14% -$4.05M 0.02% 746
2022
Q2
$20.2M Sell
175,308
-20,042
-10% -$2.31M 0.01% 905
2022
Q1
$19.5M Buy
195,350
+169,907
+668% +$16.9M 0.01% 999
2021
Q4
$3.96M Buy
25,443
+21,294
+513% +$3.31M ﹤0.01% 2433
2021
Q3
$978K Sell
4,149
-8,897
-68% -$2.1M ﹤0.01% 3675
2021
Q2
$4.43M Buy
13,046
+1,539
+13% +$522K ﹤0.01% 2269
2021
Q1
$4.66M Buy
+11,507
New +$4.66M ﹤0.01% 2125
2020
Q4
Sell
-4,008
Closed -$1.87K 4278
2020
Q3
$1.87K Sell
4,008
-27,070
-87% -$12.6K ﹤0.01% 2078
2020
Q2
$18.2M Buy
31,078
+10,546
+51% +$6.17M 0.02% 596
2020
Q1
$2.99M Sell
20,532
-11,610
-36% -$1.69M 0.01% 1400
2019
Q4
$4.6M Buy
32,142
+30,441
+1,790% +$4.36M 0.01% 1610
2019
Q3
$67K Sell
1,701
-1,098
-39% -$43.2K ﹤0.01% 3360
2019
Q2
$283K Sell
2,799
-1,030
-27% -$104K ﹤0.01% 3049
2019
Q1
$503K Buy
3,829
+2,059
+116% +$270K ﹤0.01% 2775
2018
Q4
$181K Sell
1,770
-13,019
-88% -$1.33M ﹤0.01% 3034
2018
Q3
$3.7M Buy
14,789
+9,867
+200% +$2.47M ﹤0.01% 1778
2018
Q2
$2.2M Buy
+4,922
New +$2.2M ﹤0.01% 2057
2017
Q4
Sell
-2,210
Closed -$955K 3663
2017
Q3
$955K Sell
2,210
-231
-9% -$99.8K ﹤0.01% 2319
2017
Q2
$853K Buy
+2,441
New +$853K ﹤0.01% 2309